Nektar Therapeutics
NKTR
NKTR
258 hedge funds and large institutions have $4.05B invested in Nektar Therapeutics in 2020 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 95 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.1% less ownership
Funds ownership: 6.66% → 6.56% (-0.1%)
21% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 95
Holders
258
Holding in Top 10
1
Calls
$23.7M
Puts
$21.8M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$12.8M | |
| 3 | +$10.6M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$6M |
| 5 |
Two Sigma Investments
New York
|
+$5.84M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$18.6M | |
| 3 | -$15.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.94M |